Thursday, March 23, 2023
Read Overview
Supported by independent educational grants from
Bristol Myers Squibb
Supported by independent educational grants from
Merck & Co., Inc.
Supported by independent educational grants from
Novartis Oncology
Supported by independent educational grants from
Novocure®
Developed through a partnership between Medscape and
Steering Committee Chair
Professor of Medicine, NYU Grossman School of Medicine, Deputy Director, Laura and Isaac Perlmutter Cancer Center, New York, New York
Professor of Medicine, Anheuser Busch Chair in Medical Oncology, Director, Section of Medical Oncology, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri
Assistant Professor of Medicine, Harvard Medical School, Lead, Liver Cancer Research Program, Massachusetts General Hospital Cancer Center, Boston, Massachussets
Associate Professor of Medicine, Director, Breast Oncology Program, University of Chicago Medicine, Chicago, Illinois
Ingram Professor of Medicine, Chief of Clinical Trials, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee
Associate Professor of Medicine, Lineberger Comprehensive Cancer Center, Section Chief, Thoracic and Head and Neck Oncology, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina
Steering Committee Chair
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AstraZeneca; Bristol Myers Squibb; Genentech; GlaxoSmithKline; Incyte Corporation; Moderna; Nektar Therapeutics
Owns stock, stock options, or bonds from: Biond; Evaxion; Instil Bio; Neximmune; OncoC4
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Geneplus; Inivata Limited; Merck; Precisca
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Alentis Therapeutics AG; Black Diamond; Exelixis; Genentech; H3 Biomedicine; Incyte Corporation; QED Therapeutics Inc; Servier Laboratories; Sirtex Medical Ltd; Taiho Oncology
Received grants for clinical research from: Adaptimmune, Bayer, Bristol Meyers Squibb, Eisai, Eli Lilly, Genentech, Incyte, Leap Therapeutics, Loxo Oncology, Macrogenics, Merck, Novartis, Nucana QED, Relay Therapeutics, Servier, Taiho Oncology. (To institution)
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Cardinal Health; Clovis Oncology; Fujifilm; G1 Therapeutics; Genentech; Imunomedics/Gilead; iTeos Therapeutics; MacroGenics; Merck; OncoSec Medical; Pfizer; Seagen Inc.
Received grants for clinical research from: Arvinas; AstraZeneca; Celgene; Corcept Therapeutics; Genentech/Roche; Immunomedics/Gilead; Merck; OBI Pharma Inc.; Odonate Therapeutics; OncoSec Medical; Pfizer; Seagen Inc.; Taiho Pharmaceutical
Other- DSMB Member – G1 Therapeutics
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: 3DMedicines; Alkermes, Inc.; Aravive; Arrowhead; Aveo Pharmaceuticals; Bristol Myers Squibb Company; Compugen; Corvus Pharmaceuticals; Eisai; GlaxoSmithKline; Merck; Pfizer, Inc.; GNE/Roche; Shionogi; Surface Oncology; Synthorx, Inc.
Received grants for clinical research from: Aravive; Arrowhead Pharmaceuticals; AstraZeneca; Bristol Myers Squibb Company; Dragonfly Therapeutics; Exelixis; Hoffman-LaRoche; Immunomedics; Incyte; Merck; Mirati Therapeutics; Pfizer, Inc.; Seattle Genetics; Surface Oncology; Taris
Owns stock, stock options, or bonds from: PTC Therapeutics
Steering Committee Member
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AstraZeneca; Eli Lilly; Genentech; G1 Therapeutics; Genmab; Jazz Pharmaceuticals; Nanobiotix; Sumitomo Dainippon Pharma
Owns stock, stock options, or bonds from: Achilles Therapeutics; Lyell; Nektar Therapeutics; Nuvalent; Vesselon, Inc.
